Nutex Health (NASDAQ:NUTX) versus Solventum (NYSE:SOLV) Head-To-Head Comparison

Nutex Health (NASDAQ:NUTX) and Solventum (NYSE:SOLV) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Profitability

This table compares Nutex Health and Solventum’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nutex Health	10.95%	23.50%	10.47%
Solventum	17.33%	23.51%	7.63%

Risk & Volatility

Nutex Health has a beta of 0.25, meaning that its share price is 75% less volatile than the S&P 500. Comparatively, Solventum has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500.

Institutional and Insider Ownership

5.3% of Nutex Health shares are held by institutional investors. 44.7% of Nutex Health shares are held by company insiders. Comparatively, 0.2% of Solventum shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Nutex Health and Solventum”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutex Health	$875.26 million	0.94	$70.79 million	$12.94	9.23
Solventum	$8.33 billion	1.58	$1.56 billion	$8.16	9.32

Solventum has higher revenue and earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and recommmendations for Nutex Health and Solventum, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0	1	1	0	2.50
Solventum	1	5	8	0	2.50

Nutex Health currently has a consensus price target of $205.00, indicating a potential upside of 71.62%. Solventum has a consensus price target of $84.25, indicating a potential upside of 10.74%. Given Nutex Health’s higher possible upside, equities analysts clearly believe Nutex Health is more favorable than Solventum.

Summary

Solventum beats Nutex Health on 8 of the 13 factors compared between the two stocks.

About Nutex Health

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.